Changing incidence of psychotic disorders among the young in Zurich
- PMID: 17630260
- DOI: 10.1016/j.schres.2007.06.001
Changing incidence of psychotic disorders among the young in Zurich
Abstract
There is controversy over whether the incidence rates of schizophrenia and psychotic disorders have changed in recent decades. To detect deviations from trends in incidence, we analysed admission data of patients with an ICD-8/9/10 diagnosis of psychotic disorders in the Canton Zurich / Switzerland, for the period 1977-2005. The data was derived from the central psychiatric register of the Canton Zurich. Ex-post forecasting with ARIMA (Autoregressive Integrated Moving Average) models was used to assess departures from existing trends. In addition, age-period-cohort analysis was applied to determine hidden birth cohort effects. First admission rates of patients with psychotic disorders were constant in men and showed a downward trend in women. However, the rates in the youngest age groups showed a strong increase in the second half of the 1990's. The trend reversal among the youngest age groups coincides with the increased use of cannabis among young Swiss in the 1990's.
Similar articles
-
Trends in psychiatric hospitalisation of people with schizophrenia: a register-based investigation over the last three decades.Schizophr Res. 2007 Dec;97(1-3):68-78. doi: 10.1016/j.schres.2007.07.006. Epub 2007 Aug 8. Schizophr Res. 2007. PMID: 17689930
-
Early course of schizophrenia in a representative Dutch incidence cohort.Schizophr Res. 2007 Dec;97(1-3):79-87. doi: 10.1016/j.schres.2007.07.008. Epub 2007 Aug 1. Schizophr Res. 2007. PMID: 17683911
-
Incidence and diagnostic stability of ICD-10 acute and transient psychotic disorders.Compr Psychiatry. 2008 May-Jun;49(3):255-61. doi: 10.1016/j.comppsych.2007.10.004. Epub 2007 Dec 20. Compr Psychiatry. 2008. PMID: 18396184
-
Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005.Schizophr Res. 2009 Sep;113(2-3):123-8. doi: 10.1016/j.schres.2009.05.031. Epub 2009 Jun 27. Schizophr Res. 2009. PMID: 19560900
-
Meta-analytic approaches to determine gender differences in the age-incidence characteristics of schizophrenia and related psychoses.Int J Methods Psychiatr Res. 2013 Mar;22(1):36-45. doi: 10.1002/mpr.1376. Epub 2013 Mar 4. Int J Methods Psychiatr Res. 2013. PMID: 23456888 Free PMC article.
Cited by
-
Association between Arachidonic Acid and the Risk of Schizophrenia: A Cross-National Study and Mendelian Randomization Analysis.Nutrients. 2023 Feb 27;15(5):1195. doi: 10.3390/nu15051195. Nutrients. 2023. PMID: 36904193 Free PMC article.
-
Should burden of disease estimates include cannabis use as a risk factor for psychosis?PLoS Med. 2009 Sep;6(9):e1000133. doi: 10.1371/journal.pmed.1000133. Epub 2009 Sep 29. PLoS Med. 2009. PMID: 19787023 Free PMC article.
-
Role of cannabis and endocannabinoids in the genesis of schizophrenia.Psychopharmacology (Berl). 2009 Nov;206(4):531-49. doi: 10.1007/s00213-009-1612-6. Epub 2009 Jul 24. Psychopharmacology (Berl). 2009. PMID: 19629449 Review.
-
The role of cannabis in cognitive functioning of patients with schizophrenia.Psychopharmacology (Berl). 2009 Jul;205(1):45-52. doi: 10.1007/s00213-009-1512-9. Epub 2009 Mar 27. Psychopharmacology (Berl). 2009. PMID: 19326102
-
The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study.PLoS One. 2013 Oct 24;8(10):e76635. doi: 10.1371/journal.pone.0076635. eCollection 2013. PLoS One. 2013. PMID: 24204649 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical